Le Lézard
Classified in: Health
Subject: ATY

Hagens Berman Notifies Investors That Lost Money in MacroGenics (MGNX)


SAN FRANCISCO, Sept. 18, 2019 /PRNewswire/ -- Hagens Berman notifies MGNX investors of a securities fraud lawsuit filed against MacroGenics, Inc. (MGNX).

Hagens Berman Sobol Shapiro LLP

CLASS PERIOD: Feb. 6, 2019 ? June 3, 2019
LEAD PLAINTIFF DEADLINE:
Nov. 12, 2019
Email: MGNX@hbsslaw.com
Visit: https://www.hbsslaw.com/investor-fraud/mgnx 
Call: Reed Kathrein, who is leading the firm's investigation: 510-725-3000

MGNX Securities Class Action:

According to the Complaint, Defendants concealed adverse information obtained during MacroGenics' clinical trial evaluating margetuximab, a potential breast cancer treatment.  Specifically, as early as October 2018, Defendants knew but omitted to disclose that (1) the progression-free survival ("PFS") of patients in the trial was negligible, and (2) the overall survival ("OS") was not statistically significant.  The market learned the truth on June 4, 2019, when MacroGenics disclosed the lackluster PFS and OS results.  This news drove the price of MGNX shares sharply lower that day.

If you invested in MacroGenics between Feb. 6, 2019 and June 3, 2019 and suffered significant losses (in excess of $50,000) you may qualify to be a lead plaintiff ? one who selects and oversees the attorneys prosecuting the case.  Contact Hagens Berman immediately to obtain additional information about this case or being a lead plaintiff.

"We are focused on investors' losses and the extent to which Defendants' statements may have been misleading," said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding MacroGenics should consider their options to help in the investigation or take advantage of the SEC whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email MGNX@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

 

SOURCE Hagens Berman Sobol Shapiro LLP


These press releases may also interest you

20 oct 2019
Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today...

20 oct 2019
Celltrion Healthcare today announced new data from a Phase 1 pivotal study to evaluate the pharmacokinetics (PK), efficacy and safety of CT-P13 SC compared to the CT-P13 IV formulation in people with inflammatory bowel disease (IBD). Results...

20 oct 2019
Village Health Partners has a rich connection to the North Texas community, building on local partnerships for the past 11 years. The physicians at Village Health Partners collaborate with a team of local dietitians, counselors, pharmacists, and many...

20 oct 2019
Local, regional and national leaders of the United Church of Christ announced Oct. 20 that church donations have wiped out $5.3 million in medical debt for 5,888 South Side Chicago families. Families in three ZIP codes are now receiving letters...

20 oct 2019
LiveWell TMS, a new depression treatment facility, announced today it will host a grand opening event on Thursday, October 24, in celebration of its new location and in honor of National Depression Awareness Month. Co-founded by doctors Nina and Eric...

20 oct 2019
JBRF is excited to announce the appointment of Elizabeth Errico as the organization's executive director. Ms. Errico moves into the role from her former position as a board member and the director of education. Ms. Errico joins the staff of JBRF as...



News published on 18 september 2019 at 20:03 and distributed by: